Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $355M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS INC | 2,531,800 | $112M | 31.6% | $16.31 | +236.7% | COM | 77313F106 |
| ANAB | ANAPTYSBIO INC | 2,628,678 | $56.65M | 15.9% | $21.51 | +17.3% | COM | 032724106 |
| — | APTEVO THERAPEUTICS INC | 1,760,000 | $53.72M | 15.1% | $36.65 | — | COM NEW | 03835L207 |
| — | ODONATE THERAPEUTICS INC | 15,514,566 | $53.06M | 14.9% | $24.10 | — | COM | 676079106 |
| — | LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $39.88M | 11.2% | $10.35 | — | COM | 503459604 |
| — | VINCERX PHARMA INC | 500,000 | $9.65M | 2.7% | $19.30 | — | COM NEW | 92731L106 |
| CHRS | COHERUS BIOSCIENCES INC | 650,000 | $9.497M | 2.7% | $17.90 | -5.1% | COM | 19249H103 |
| RLMD | RELMADA THERAPEUTICS INC | 200,000 | $7.042M | 2.0% | $28.22 | +24.0% | COM | 75955J402 |
| — | BCTG ACQUISITION CORP | 468,750 | $5.213M | 1.5% | $10.36 | — | COM | 05492W103 |
| EQ | EQUILLIUM INC | 600,000 | $4.29M | 1.2% | $5.23 | +37.2% | COM | 29446K106 |
| — | VINCERX PHARMA INC | 1,014,368 | $4.098M | 1.2% | $3.80 | — | *W EXP 12/24/202 | 92731L114 |